ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2022, Vol. 31 ›› Issue (1): 63-67.DOI: 10.3969/j.issn.1006-298X.2022.01.013

• • 上一篇    下一篇

足细胞能量代谢调节因子与糖尿病肾病

LI Jiarong, XIE Honglang   

  • 出版日期:2022-02-28 发布日期:2022-02-18

Podocyte energy metabolism regulatory factors and diabetic nephropathy

  • Online:2022-02-28 Published:2022-02-18

摘要: 足细胞结构和功能异常是糖尿病肾病(DN)发生蛋白尿并不断进展的重要原因。足细胞主要通过糖酵解供能,而线粒体稳态对于足细胞正常发挥生物学功能极为重要。研究发现,糖尿病时足细胞胰岛素敏感性下降,线粒体功能障碍进而导致足细胞能量利用障碍和足细胞损伤。AMP激活的蛋白激酶(AMPK)/沉默信息调节因子1(SIRTl)/过氧化物酶体增殖物激活受体γ(PPARγ)共激活因子1α(PGC1α)通路是足细胞能量代谢的重要调节因素,维持线粒体稳态并抑制氧化应激,对糖尿病足细胞发挥保护作用。本文将简介足细胞能量代谢相关调节因子对DN足细胞保护作用和DN相关的治疗策略。


关键词: 足细胞能量代谢调节因子,糖尿病肾病,AMP激活的蛋白激酶,沉默信息调节因子1,

Abstract: The abnormality of podocyte structure and function is an important reason for the occurrence and progression of proteinuria in diabetic nephropathy (DN). Podocytes are mainly energized by glycolysis, and mitochondrial homeostasis is vital for podocytes to perform their biological functions normally. Studies have found that podocyte insulin sensitivity decreases and mitochondrial dysfunction leads to podocyte energy utilization disorder and podocyte injury. AMPactivated protein kinase (AMPK)/silencing information regulator 1 (SIRTl)/peroxisome proliferatoractivated receptor γ (PPARγ) coactivator1 α (PGC1 α) pathway is an important regulator of podocyte energy metabolism, which maintains mitochondrial homeostasis,inhibits oxidative stress and plays a protective role in diabetic podocytes. This article will briefly introduce the protective effects of podocyte energy metabolism related regulators on DN podocytes and the therapeutic strategies related to DN.


Key words: podocyte energy metabolism regulatory factors, diabetic nephropathy, AMP-activated protein kinasesirtuin-1, peroxisome proliferatoractivated receptor coactivator-1 α